FIGURE 1.

Structure of native agonists of the purinergic receptors, including both P2Rs (1–8) and ARs (9), and structures of agonist (10–20) and antagonist (21–37) ligands developed for the ARs, as described in the text. Compounds 24 – 26 inhibit PDEs, but are weaker in inhibiting ARs.